These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26978495)

  • 41. [Affectivity and alexithymia: two dimensions explicative of the relationship between anxiety and depressive symptoms].
    Bonnet A; Bréjard V; Pasquier A; Pedinielli JL
    Encephale; 2012 Jun; 38(3):187-93. PubMed ID: 22726406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain.
    Nagashima W; Kimura H; Ito M; Tokura T; Arao M; Aleksic B; Yoshida K; Kurita K; Ozaki N
    Clin Neuropharmacol; 2012; 35(6):273-7. PubMed ID: 23123692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinguishing anxiety and depression in self-report: purification of the Beck Anxiety Inventory and Beck Depression Inventory-II.
    Stulz N; Crits-Christoph P
    J Clin Psychol; 2010 Sep; 66(9):927-40. PubMed ID: 20694959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting.
    Gibiino S; Mori E; De Ronchi D; Serretti A
    J Clin Psychopharmacol; 2013 Aug; 33(4):565-9. PubMed ID: 23764690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A spectrum model for depressive conditions: extrapolation of the atypical depression prototype.
    Parker GB; Crawford J
    J Affect Disord; 2007 Nov; 103(1-3):155-63. PubMed ID: 17306888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DSM-III personality disorders and the outcome of treated panic disorder.
    Reich JH
    Am J Psychiatry; 1988 Sep; 145(9):1149-52. PubMed ID: 2901236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emotional distress and medication use in two acute pain populations: jaw and low back.
    Edwards D; Gatchel R; Adams L; Stowell AW
    Pain Pract; 2006 Dec; 6(4):242-53. PubMed ID: 17129305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The uses of hypnotically produced emotional responses in therapy.
    Walker WL; Rippingale C
    Aust N Z J Psychiatry; 1973 Mar; 7(1):27-31. PubMed ID: 4516338
    [No Abstract]   [Full Text] [Related]  

  • 52. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of depression and chronic pain on psychosocial and physical functioning.
    Holzberg AD; Robinson ME; Geisser ME; Gremillion HA
    Clin J Pain; 1996 Jun; 12(2):118-25. PubMed ID: 8776551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment patterns in psychiatry: relationships to symptom features and aging.
    Fracchia J; Sheppard C; Merlis S
    J Am Geriatr Soc; 1973 Mar; 21(3):134-8. PubMed ID: 4144996
    [No Abstract]   [Full Text] [Related]  

  • 55. Depression and anxiety in complex partial seizures.
    Perini G; Mendius R
    J Nerv Ment Dis; 1984 May; 172(5):287-90. PubMed ID: 6425454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Childhood experiences and personality traits in patients with motor conversion symptoms.
    Binzer M; Eisemann M
    Acta Psychiatr Scand; 1998 Oct; 98(4):288-95. PubMed ID: 9821450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot study of the short-term antianxiety effects of molindone HCl.
    Kellner R; Gervais RH; Pathak D
    J Clin Pharmacol New Drugs; 1972; 12(11):472-6. PubMed ID: 4563663
    [No Abstract]   [Full Text] [Related]  

  • 58. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory.
    Derogatis LR; Lipman RS; Rickels K; Uhlenhuth EH; Covi L
    Behav Sci; 1974 Jan; 19(1):1-15. PubMed ID: 4808738
    [No Abstract]   [Full Text] [Related]  

  • 59. The psychological assessment of patients with chronic pain.
    Lebovits AH
    Curr Rev Pain; 2000; 4(2):122-6. PubMed ID: 10998723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An overview of which health domains to consider and when to apply them in measurement-based care for depression and anxiety disorders.
    Bech P; Timmerby N
    Nord J Psychiatry; 2018 Jul; 72(5):367-373. PubMed ID: 29714082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.